Novel urushiol derivatives as HDAC8 inhibitors: rational design, virtual screening, molecular docking and molecular dynamics studies.

about

Novel urushiol derivatives as HDAC8 inhibitors: rational design, virtual screening, molecular docking and molecular dynamics studies.

Item

http://www.wikidata.org/entity/Q53208721

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Novel urushiol derivatives as ...... nd molecular dynamics studies.

@en

Novel urushiol derivatives as ...... nd molecular dynamics studies.

@nl

type

Item

label

Novel urushiol derivatives as ...... nd molecular dynamics studies.

@en

Novel urushiol derivatives as ...... nd molecular dynamics studies.

@nl

prefLabel

Novel urushiol derivatives as ...... nd molecular dynamics studies.

@en

Novel urushiol derivatives as ...... nd molecular dynamics studies.

@nl

P1476

Novel urushiol derivatives as ...... nd molecular dynamics studies.

@en

P2093

Chengzhang Wang

http://www.w3.org/2001/XMLSchema#string

Hao Zhou

http://www.w3.org/2001/XMLSchema#string

Ran Tao

http://www.w3.org/2001/XMLSchema#string

Tao Deng

http://www.w3.org/2001/XMLSchema#string

Wenjun Li

http://www.w3.org/2001/XMLSchema#string

P2860

Histone deacetylases (HDACs): characterization of the classical HDAC family

Clinical development of histone deacetylase inhibitors as anticancer agents

Atmospheric pressure ionization LC-MS-MS determination of urushiol congeners.

Discovery of a small molecular compound simultaneously targeting RXR and HADC: design, synthesis, molecular docking and bioassay.

Modular synthesis and biological activity of pyridyl-based analogs of the potent Class I Histone Deacetylase Inhibitor Largazole.

Fragment based G-QSAR and molecular dynamics based mechanistic simulations into hydroxamic-based HDAC inhibitors against spinocerebellar ataxia.

Histone deacetylase inhibitors and cancer: from cell biology to the clinic.

Molecular docking and dynamics simulation study of flavonoids as BET bromodomain inhibitors.

Structural insights into conformational stability of both wild-type and mutant EZH2 receptor

Computational studies on the histone deacetylases and the design of selective histone deacetylase inhibitors.

P304

1966-1978

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/07391102.2017.1344568

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-07-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28632421

http://www.w3.org/2001/XMLSchema#string

P921

molecular design